Standard and Additional Patch Tests Across 937 Patients
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: What extra diagnostic yield came from additional patch-test allergens beyond a standard series?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 937 patients tested with a standard series; 897 also received nonstandard allergen testing. |
| Design | Clinical epidemiologic analysis of patch-test positivity and occupational categories. |
| Comparator | Standard-series versus additional-series yield and occupation-specific positive reactions. |
| Timepoint | One clinical testing program; no prospective follow-up is reported. |
| Key result | 392/937 (41.8%) reacted to at least one standard allergen. Among 897 tested with nonstandard allergens, 124 (13.8%) had at least one positive reaction; ammonium persulfate was the most frequent additional allergen. |
| Funding/conflict context | The English PubMed record lists no grant or conflict statement. |
What was actually measured?
392/937 (41.8%) reacted to at least one standard allergen. Among 897 tested with nonstandard allergens, 124 (13.8%) had at least one positive reaction; ammonium persulfate was the most frequent additional allergen.
Different series test different candidate exposures, so their yields are not a head-to-head diagnostic-accuracy comparison. Positive reactions still require clinical and occupational relevance.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
Clinical referral sample, nonrandom selection of additional allergens, multiple comparisons, English-abstract-only access and no workforce denominators limit inference.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 14979180
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Patch Tests in 449 Referred Construction Workers
- Dyshidrotic Eczema Findings in 286 Metalworkers
- Spanish NOSQ Validation in 80 Cleaners and 2,546 Records
- Occupational Nickel Relevance in 368 Sensitized Patients
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.